Beta-Haemolytic Group A, C and G Streptococcal Infections in Southern Hungary: A 10-Year Population-Based Retrospective Survey (2008–2017) and a Review of the Literature

References

• Sktkiewicz I, Hryniewicz W. Pyogenic streptococci–danger of re-emerging pathogens. Pol J Microbiol. 2010;59:219–226. doi:10.33073/pjm-2010-03421466038
   PubMed Web of Science ®Google Scholar
• Janda WM, Stroger JH. The genus streptococcus part I emerging pathogens in the “Pyogenic Cocci” and the “Streptococcus Bovis” groups. Clin Microbiol Newslett. 2014;36:157–166. doi:10.1016/j.clinmicnews.2014.10.001
   Google Scholar
• Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002;15:613–630.12364372
   PubMed Web of Science ®Google Scholar
• Gajdács M. Taxonomy and nomenclature of bacteria with clinical and scientific importance: current concepts for pharmacists and pharmaceutical scientists. Acta Pharm Hung. 2019;89:99–108. doi:10.33892/aph.2019.89.99-108
   Google Scholar
• Steer AC, Jenney A, Kado J, Good MF, Batzloff M, Waqatakirewa L, Mullholland EK, Carapetis JR. Prospective surveillance of invasive Group A streptococcal disease, Fiji, 2005-2007.Emerg Infect Dis2009;15;216–222.
   Google Scholar
• Hryniewicz W, Heczko PB, Lütticken R, Wannamaker LW. Comparison of three methods for grouping Streptococci. J Clin Microbiol. 1976;4:28–31.956361
   PubMed Web of Science ®Google Scholar
• Tagini F, Aubert B, Troillet N, et al. Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes infections. Eur J Clin Microbiol Infect Dis. 2017;36:1173–1180. doi:10.1007/s10096-017-2905-z28124734
   PubMed Web of Science ®Google Scholar
• Babbar A, Itzek A, Pieper DH, Nitsche-Schmitz DP. Detection of Streptococcus pyogenes virulence genes in Streptococcus dysgalactiae subsp. equisimilis from Vellore, India. Folia Microbiol. 2018;63:581–586. doi:10.1007/s12223-018-0595-229532420
   PubMed Web of Science ®Google Scholar
• Shannon BA, McCormick JK, Schievert PM. Toxins and superantigens of group A streptococci. Gram-Positive Pathogens. 2018;55–66. doi:10.1128/microbiolspec.GPP3-0054-2018
   Google Scholar
• Šmitran A, Vuković D, Opavski N, et al. Influence of subinhibitory antibiotic concentration on Streptococcus pyogenes adherence and biofilm production. Acta Microbiol Immunol Hung. 2018;653:229–240. doi:10.1556/030.65.2018.026
   Web of Science ®Google Scholar
• Klos M, Wójkowska-Mach J. Pathogenicity of virulent species of group C streptococci in human. Can J Infect Dis Med Microbiol. 2017;2017:9509604. doi:10.1155/2017/950960428694832
   PubMed Web of Science ®Google Scholar
• Oliver J, Malliya Wadu E, Pierse N, Moreland NJ, Willamson DA, Baker MG. Group A Streptococcus pharyngitis and pharyngeal carriage: a meta-analysis. PLoS One. 2018;12:e0006335. doi:10.1371/journal.pntd.0006335
   Web of Science ®Google Scholar
• Speert DP. Group A streptococcal carriage can the troll be tamed?. Paediatr Child Health. 1998;3:229–230. doi:10.1093/pch/3.4.22920401252
   PubMedGoogle Scholar
• Brandt CM, Spellerberg B. Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis. 2009;49:766–772. doi:10.1086/60508519635028
   PubMed Web of Science ®Google Scholar
• Nelson GE, Pondo T, Toews KA, et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Clin Infect Dis. 2016;63:478–486. doi:10.1093/cid/ciw24827105747
   PubMed Web of Science ®Google Scholar
• Martin JM. The mysteries of streptococcal pharyngitis. Cur Treat Opinions Pediatr. 2015;1:180–189. doi:10.1007/s40746-015-0013-9
   Google Scholar
• Basetti S, Hodgson J, Rawson TM, Majeed A. Scarlet fever: a guide for general practitioners. London J Prim Care (Abingdon). 2017;9:77–79. doi:10.1080/F17571472.2017.1365677
   PubMed Web of Science ®Google Scholar
• Kuriyan AE, Weiss KD, Flynn HW, et al. Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol. 2014;157:744–780. doi:10.1016/j.ajo.2013.12.026
   Web of Science ®Google Scholar
• Harris CM, Johnikin M, Rhodes H, et al. Lemierre’s syndrome resulting from streptococcal induced otitis media and mastoiditis: a case report. J Med Case Reports. 2009;3:e6658. doi:10.1186/1752-1947-3-6658
   PubMedGoogle Scholar
• Dubost JJ, Soubrier M, De Champs C, Ristori JM, Sauvezie B. Streptococcal septic arthritis in adults. A study of 55 cases with a literature review. Joint Bone Spine. 2004;71:303–311. doi:10.1016/S1297-319X(03)00122-215288856
   PubMed Web of Science ®Google Scholar
• Ibia O, Imoisili M, Pikis A. Group A beta-hemolytic streptococcal osteomyelitis in children. Pediatrics. 2003;112:e22–26. doi:10.1542/peds.112.1.e2212837901
   PubMed Web of Science ®Google Scholar
• Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in Western Norway: incidence and clinical features. Lancet. 1994;344:1111–1115. doi:10.1016/S0140-6736(94)90629-77934492
   PubMed Web of Science ®Google Scholar
• Tanaka H, Katsuragi S, Hasegawa J, et al. The most common causative bacteria in maternal sepsis-related deaths in Japan were group A Streptococcus: a nationwide survey. J Infect Chemother. 2019;25:41–44. doi:10.1016/j.jiac.2018.10.00430377069
   PubMed Web of Science ®Google Scholar
• Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome (1993) A retrospective population-based study. JAMA. 1993;269:384–389. doi:10.1001/jama.1993.035000300820378418346
   PubMed Web of Science ®Google Scholar
• Fanella S, Embree J. Group A streptococcal meningitis in a pediatric patient. Can J Infect Dis Med Microbiol. 2008;19:306–308. doi:10.1155/2008/59458319436512
   PubMedGoogle Scholar
• Yung L, Rashid M, Brau N. Group C streptococcus dysgalactiae subsp.equisimilis (SDSE) endocarditis with endogenous endophthalmitis and aortic root abscess. IDCases. 2019;15:e00513. doi:10.1016/j.idcr.2019.e0051330899671
   PubMed Web of Science ®Google Scholar
• Ikebe T, Okuno R, Uchitani Y, et al. T serotyping of group a streptococcus isolated from patients with pharyngitis or streptococcal toxic shock syndrome in Japan between 2005 and 2017. J Infect Chemother. 2020;26:157–161.31735631
   PubMed Web of Science ®Google Scholar
• Cunningham MW. Pathogenesis of group A streptococci. Clin Microbiol Rev. 2000;13:470–491. doi:10.1128/CMR.13.3.470-511.200010885988
   PubMed Web of Science ®Google Scholar
• Muhtarova A, Mihova K, Markovksa R, Mitov I, Kaneva R, Gergova R. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates. Acta Microbiol Immunol Hung. 2019;66:1–4. doi:10.1556/030.66.2019.03329968490
   PubMed Web of Science ®Google Scholar
• Burián K, Berencsi K, Endrész V, et al. Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice. Clin Vaccine Immunol. 2001;8:1263–1266.
   Google Scholar
• Tatara K, Gotoh K, Okumiya K, et al. Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan. J Infect Chemother. 2020;26:280–284. doi:10.1016/j.jiac.2019.10.00431680034
   PubMed Web of Science ®Google Scholar
• Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685–694. doi:10.1016/S1473-3099(05)70267-X16253886
   PubMed Web of Science ®Google Scholar
• Baracco GJ. infections caused by group C and G streptococcus (streptococcus dysgalactiae subsp. equisimilis and others): epidemiological and clinical aspects. Gram-Positive Pathogens. 2019;275–283. doi:10.1128/microbiolspec.GPP3-0016-2018
   Google Scholar
• Shahin VA, Saba M, Greene JN. A retrospective chart review on the clinical characteristics and outcomes of cancer patients with group C, F, or G β-hemolytic streptococcal infections. Infect Dis Clin Pract. 2019;27:205–210. doi:10.1097/IPC.0000000000000723
   Web of Science ®Google Scholar
• Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med. 2002;112:622–626. doi:10.1016/S0002-9343(02)01117-812034411
   PubMed Web of Science ®Google Scholar
• Meisal R, Høiby EA, Aaberge IS, Caugant DA. Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003. J Clin Microbiol. 2008;46:2102–2105. doi:10.1128/JCM.00363-0818417661
   PubMed Web of Science ®Google Scholar
• Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects. Clin Microbiol Infect. 2005;11:569–576. doi:10.1111/j.1469-0691.2005.01169.x15966976
   PubMed Web of Science ®Google Scholar
• Oppegaard O, Hylvaganam H, Kittang BR. Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect. 2015;21:171–178. doi:10.1016/j.cmi.2014.08.01925658557
   PubMed Web of Science ®Google Scholar
• Gajdács M, Burián K, Terhes G. Resistance levels and epidemiology of non-fermenting gram-negative bacteria in urinary tract infections of inpatients and outpatients (RENFUTI): a 10-year epidemiological snapshot. Antibiotics. 2019;8:e143. doi:10.3390/antibiotics803014331505817
   PubMed Web of Science ®Google Scholar
• Hospital Bed Count and Patient Turnover Report. 2017 National health insurance fund of Hungary. Available from: http://www.neak.gov.hu/felso_menu/szakmai_oldalak/publikus_forgalmi_adatok/gyogyito_megelozo_forgalmi_adat/fekvobeteg_szakellatas/korhazi_agyszam.html. Accessed 515, 2020.
   Google Scholar
• Rudolph K, Bruce MG, Bruden D, et al. Epidemiology of invasive group A streptococcal disease in Alaska, 2001 to 2013. J Clin Microbiol. 2016;54:134–141. doi:10.1128/JCM.02122-1526560536
   PubMed Web of Science ®Google Scholar
• Jensen CS, Dam-Nielsen C, Arpi M. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry identification of large colony beta-hemolytic streptococci containing Lancefield groups A, C, and G. Infect Dis (London). 2015;47:575–579. doi:10.3109/23744235.2015.104394025960250
   PubMed Web of Science ®Google Scholar
• Balogh EP, Faludi I, Virók DP, Endrész V, Burián K. Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity. Int J Med Microbiol. 2015;301:252–259. doi:10.1016/j.ijmm.2010.08.020
   Web of Science ®Google Scholar
• EUCAST Clinical Breakpoints and Dosing. Available from: https://www.eucast.org/clinical_breakpoints/. Accessed 515, 2020.
   Google Scholar
• Camara M, Dieng A, Boye CSB. Antibiotic susceptibility of streptococcus pyogenes isolated from respiratory tract infections in Dakar, Senegal. Microbiol Insights. 2013;6:71–75. doi:10.4137/MBI.S1299624826076
   PubMedGoogle Scholar
• Parks T, Barrett L, Jones N. Invasive streptococcal disease: a review for clinicians. Brit Med Bulletin. 2015;115:77–89. doi:10.1093/bmb/ldv027
   PubMed Web of Science ®Google Scholar
• Allen UD, Moore DL. Invasive group A streptococcal disease: management and chemoprophylaxis. Paediatr Child Health. 2010;15:295–298. doi:10.1093/pch/15.5.29521532795
   PubMed Web of Science ®Google Scholar
• Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the infectious diseases society of America. Clin Infect Dis. 2012;55:e102. doi:10.1093/cid/cis847
   Web of Science ®Google Scholar
• Falagas ME, Matthaiou DK, Karveli EA, Peppas G. Meta‐analysis: randomized controlled trials of clindamycin/aminoglycoside vs. β‐lactam monotherapy for the treatment of intra‐abdominal infections. Alimentary Pharmacol Ther. 2007;25:537–556. doi:10.1111/j.1365-2036.2006.03240.x
   PubMed Web of Science ®Google Scholar
• Castells M, Khan DA, Phillips EJ. Penicillin allergy. N Engl J Med. 2019;381:2338–2351. doi:10.1056/NEJMra180776131826341
   PubMed Web of Science ®Google Scholar
• Gajdács M. Intravenous or oral antibiotic therapy: sophie’s choice? Gen Int Med Clin Innov. 2019;4:1–2. doi:10.15761/GIMCI.1000176
   Google Scholar
• Tarlow MJ. Macrolides in the management of streptococcal pharyngitis/tonsillitis. Pediatr Infect Dis J. 1997;16:444–448. doi:10.1097/00006454-199704000-000289109157
   PubMed Web of Science ®Google Scholar
• Vannice KS, Ricaldi J, Nanduri S, et al. Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to β-lactam antibiotics. Clin Infect Dis. 2020;71:201–204. doi:10.1093/cid/ciz100031630171
   PubMed Web of Science ®Google Scholar
• Fuursted K, Stegger M, Hoffmann S, et al. Description and characterization of a penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis clone isolated from blood in three epidemiologically linked patients. J Antimicrob Chemother. 2016;71:3376–3380. doi:10.1093/jac/dkw32027585966
   PubMed Web of Science ®Google Scholar
• Southon SB, Beres SB, Kachroo P, et al. Population genomic molecular epidemiological study of macrolide-resistant Streptococcus pyogenes in Iceland, 1995 to 2016: identification of a large clonal population with a pbp2x mutation conferring reduced in vitro β-lactam susceptibility. J Clin Microbiol. 2020;58:e00638–20. doi:10.1128/JCM.00638-2032522827
   PubMed Web of Science ®Google Scholar
• Haenni M, Lupo A, Madec JY. Antimicrobial resistance in streptococcus spp. Antimicrobial Resistance in Bacteria from Livestock and Companion Animals. 2018;159–184. doi:10.1128/microbiolspec.ARBA-0008-2017
   Google Scholar
• Schmitz FJ, Verhoef J, Fluit AC; The Sentry Participants Group. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. J Antimicrob Chemother. 1999;43:783–792. doi:10.1093/jac/43.6.783.10404317
   PubMed Web of Science ®Google Scholar
• Grivea IN, Syrogiannopoulos GA, Muchoula AN, et al. emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017. PLoS One. 2020;15:e0232777. doi:10.1371/journal.pone.023277732379802
   PubMed Web of Science ®Google Scholar
• Richter SS, Diekema DJ, Heilmann KP, et al. Fluoroquinolone resistance in streptococcus pyogenes. Clin Infect Dis. 2003;36:380–383. doi:10.1086/34590412539083
   PubMed Web of Science ®Google Scholar
• Sayyahfar S, Fahimzad A, Naddaf A, Tavassoli S. Antibiotic susceptibility evaluation of group A streptococcus isolated from children with pharyngitis: a study from Iran. Infect Chemother. 2015;47:225–230. doi:10.3947/ic.2015.47.4.22526788405
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control. Antimicrobial consumption - Annual Epidemiological Report for 2018. Available online: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-consumption-europe-2018. Accessed 515, 2020.
   Google Scholar
• Lambertsen LM, Ingels H, Sconheyder HC, Hoffmann S, Mainardi JL; Danish Streptococcal Surveillance Collaboration Group 2011. Nationwide laboratory-based surveillance of invasive beta-haemolytic streptococci in Denmark from 2005 to 2011. Clin Microbiol Infect. 2014;20:O216–O223. doi:10.1111/1469-0691.1237824125634
   PubMed Web of Science ®Google Scholar
• Zaoutis T, Attia M, Gross R, Klein J. The role of group C and group G streptococci in acute pharyngitis in children. Clin Microbiol Infect. 2002;10:37–40. doi:10.1111/j.1469-0691.2004.00732.x
   Web of Science ®Google Scholar
• Montes M, Ardanuy C, Tamayo E, Doménech A, Linares J, Pérez-Trallero E. Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998–2009): comparison with non-invasive isolates. Eur J Clin Microbiol Infect Dis. 2011;30:e1295. doi:10.1007/s10096-011-1226-x
   Web of Science ®Google Scholar
• Imöhl M, Reniert RR, Ocklenburg C, van der Linden M. Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003–2007. Pathogens Dis. 2010;58:389–396. doi:10.1111/j.1574-695X.2010.00652.x
   Web of Science ®Google Scholar
• Darenberg J, Luca-Harari B, Jasin A, et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis. 2007;45:450–458. doi:10.1086/51993617638193
   PubMed Web of Science ®Google Scholar
• Ho PL, Johnson DR, Yue AW, et al. Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong. J Clin Microbiol. 2003;41:937–942. doi:10.1128/jcm.41.3.937-942.200312624012
   PubMed Web of Science ®Google Scholar
• Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjanen J. Clinical presentations and epidemiology of beta-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect. 2009;15:286–288. doi:10.1111/j.1469-0691.2008.02672.x
   Web of Science ®Google Scholar
• Harris P, Siew P, Proud M, Buettner P, Norton R. Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clin Microbiol Infect. 2011;17:1216–1222. doi:10.1111/j.1469-0691.2010.03427.x21073630
   PubMed Web of Science ®Google Scholar
• Wong SS, Lin YS, Mathew L, Rajagopal L, Sepkowitz D. Increase in group G streptococcal infections in a community hospital, New York, USA. Emerg Infect Dis. 2009;15:991–993. doi:10.3201/eid1506.080666
   PubMed Web of Science ®Google Scholar
• Bruun T, Kittang BR, de Hoog BJ, et al. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway. Clin Microbiol Infect. 2013;19:E545–550. doi:10.1111/1469-0691.1227623795951
   PubMed Web of Science ®Google Scholar
• Hashikawa S, Iinuma Y, Furushita M, et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol. 2004;42:186–192.14715751
   PubMed Web of Science ®Google Scholar
• Loubinoux J, Plainvert C, Collobert G, et al. Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010. J Clin Microbiol. 2013;51:2724–2727. doi:10.1128/JCM.01262-1323698531
   PubMed Web of Science ®Google Scholar
• Lamagni TL, Darenberg J, Luca-Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2008;46:2359–2367. doi:10.1128/JCM.00422-0818463210
   PubMed Web of Science ®Google Scholar
• O’Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis. 2007;45(7):853–862. doi:10.1086/52126417806049
   PubMed Web of Science ®Google Scholar
• Nelson GE, Pondo T, Toews KA, et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Rev Infect Dis. 2016;63:478–486. doi:10.1093/cid/ciw248
   Google Scholar
• Lamagni TL, Efstrartiou A, Vuopio-Varkila J, Jasir A, Schalén C; Strep-EURO group. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Eurosurveillance. 2005;10:e563. doi:10.2807/esm.10.09.00563-en
   Google Scholar
• Gattringer R, Sauermann R, Lagler H, et al. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenescollected in Austria and Hungary. Int J Antimicrob Agents. 2004;24:92–95. doi:10.1016/j.ijantimicag.2004.01.009
   Web of Science ®Google Scholar
• Krucsó B, Gacs M, Libisch B, et al. Molecular characterisation of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005. Eur J Clin Microbiol Infect Dis. 2007;26:807–811. doi:10.1007/s10096-007-0359-417665233
   PubMed Web of Science ®Google Scholar